Sab Biotherapeutics Inc. (SABSW)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 01
-0
-23.4234%
$
106.1K Market Cap
0.1 P/E Ratio
- Div Yield
400 Volume
0 Eps
$ 0.01
Previous Close Investors:
Want to track SABSW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sab Biotherapeutics Inc. (SABSW) Statistics
Valuation metrics
Market Cap 106.1K
Enterprise value 19.2M
Trailing P/E (ttm) 8.16
Forward P/E -
PEG ratio -0.25
Price/Sales (ttm) -
Price/Book (mrq) 0.83
Enterprise Value/Revenue -
Enterprise Value/EBITDA 6.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.8K
Average volume (90 days) 33.62K
Price summary
52-Week low 0.01
52-Week high 0.06
Beta -
50-Day moving average 0.02
200-Day moving average 0.03
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0%
Return on equity -0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 11.45%
Book value per share (mrq) 4.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
